However, it is not licensed as an anti-inflammatory treatment, and any such effects are considered secondary to its metabolic actions
Figure 4 shows that a higher total energy intake was significantly associated with higher AUC for plasma GLP-1 ( = 0.268, P = 0.033) among acarbose users but with lower AUC for plasma GLP-1 among metformin users ( = 0.264 acarbose, P = 0.049)
Individuals will be provided Wegovy on prescription as part of a specialised weight management service and for a maximum of two years
Case reports were shared by some of the authors and discussed during the expert panel and reported in Supplementary Material
Benito J, Hongbo L, Wilson WR, Melink TJ, Feliu J, Konoplev S, Estey E, Kantarjian H, Gutheil JC, Andreeff M , Konopleva M
The Inspira team is experienced in working with insurance companies to obtain appropriate coverage and help decrease cost when applicable